omniture
logo
Search
NEXTBIOMEDICAL CO., LTD.
Media Room

Latest News

rss

Nexsphere-F™ Clinical Study Published in Radiology, Showing 57% Reduction in Knee Osteoarthritis Pain

SEOUL, South Korea, July 6, 2026 /PRNewswire/ -- NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), an inno...

2026-07-06 21:00 4017

NEXTBIOMEDICAL Secures Exclusive Distribution Agreement for Nexsphere-F™ in Japan

SEOUL, South Korea, April 9, 2026 /PRNewswire/ -- NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), an inn...

2026-04-09 21:00 5297

NEXTBIOMEDICAL Secures Health Canada Approval for Nexsphere-F™ in Musculoskeletal Pain Embolization

SEOUL, South Korea, Jan. 29, 2026 /PRNewswire/ -- NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), an inn...

2026-01-29 22:00 9042

NEXTBIOMEDICAL Announces First Patient Enrolled in U.S. FDA Pivotal Trial of Nexsphere-F™ for Knee Osteoarthritis Pain

* RESORB Study Marks Major Step Toward U.S. Regulatory Approval and Global Commercialization SEOU...

2025-10-13 21:00 2367

NEXTBIOMEDICAL, Fast Resorbable Microsphere 'Nexsphere-F' : Clinical Study Results on 155 Patients Published in the JVIR

* Safety and Excellent Pain Relief Effect after Musculoskeletal Pain Embolization SEOUL, South Ko...

2025-03-17 21:00 3400

NEXTBIOMEDICAL Secures FDA Breakthrough Device Designation for Innovative Resorbable Microsphere 'Nexsphere-F™'

Pioneering a Paradigm Shift in Pain Treatment, Accelerating Global Market Expansion SEOUL, South K...

2025-03-06 22:00 3901

NEXTBIOMEDICAL Receives IDE Approval from FDA for Nexsphere-F™, an Embolic Microsphere for Use in Genicular Artery Embolization (GAE) for Knee Osteoarthritis: The U.S. RESORB Trial Launches

SEOUL, South Korea, Jan. 15, 2025 /PRNewswire/ -- NEXTBIOMEDICAL CO., LTD, a KOSDAQ-listed innovati...

2025-01-15 22:00 4688